Eisai

Research-based pharmaceutical company developing oncology and neurology medicines for patients and healthcare providers

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

Recent signals

What changed at Eisai in the last 6 months, newest first. Each line links to its public source.

Get signals like these for the companies you sell to →

About Eisai

Eisai Europe is the European operation of Eisai, a research-based pharmaceutical company. It offers medicines in the oncology and neurology therapy areas and describes its corporate concept as human health care (hhc), with patients and their families at the centre.

The company sells prescription medicines in these therapy areas. Its customers are patients and the healthcare professionals who treat them.

Eisai has over 80 years of history and employs more than 10,000 people worldwide across operations in Asia, Australia, Europe, the Middle East, Latin America, New Zealand and the United States. It runs 15 drug discovery, research and development, and clinical research sites globally and has more than 40 subsidiaries. Its EMEA Knowledge Centre hosts an emerging talent programme. Current openings include field sales and medical science liaison roles in the United States, plus clinical R&D IT, biostatistics, and manufacturing roles.

Product: Prescription medicines in the oncology and neurology therapy areas.

Jobs at Eisai

No open positions in Europe right now.

Open roles at Eisai in the Americas (16)

United States 16. From Eisai's careers page or applicant tracking system; each role links to the employer.

Newest 12 of 16.

More biotech & pharma companies

  • ElevateBio

    Contract development and manufacturing of cell and gene therapies for biopharma developers, from gene editing through cGMP production
    United StatesBiotech & pharma
    New on Evolc
  • Emerald Cloud Lab

    Remotely controlled life science lab letting pharma, biotech and academic teams run wet-lab experiments through software
    United StatesBiotech & pharma
    New on Evolc
  • Encoded Therapeutics

    Develops gene therapies for people with neurological disorders using targeted genetic medicines
    United StatesBiotech & pharma
    New on Evolc
  • Entrada Therapeutics

    Intracellular therapeutics for patients with neuromuscular, ocular, metabolic and immunological diseases
    Boston, United StatesBiotech & pharma
    New on Evolc
  • Erasca

    Clinical-stage precision oncology company developing therapies that target the RAS/MAPK cancer signaling pathway
    United StatesBiotech & pharma
    New on Evolc
  • EVERY™

    Animal-free egg white protein ingredients (OvoPro) made by precision fermentation for food manufacturers and foodservice
    United StatesBiotech & pharma
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content delivery

  • CloudflareHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content management

  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Cloudflare TurnstileHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • Contact Form 7High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.